Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer

Published:2020-05-04 Issue:6 Volume:130 Page:3005-3020
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Xing Manjie,Ooi Wen Fong,Tan Jing,Qamra Aditi,Lee Po-Hsien,Li Zhimei,Xu Chang,Padmanabhan Nisha^ORCID,Lim Jing Quan^ORCID,Guo Yu Amanda,Yao Xiaosai^ORCID,Amit Mandoli,Ng Ley Moy,Sheng Taotao,Wang Jing,Huang Kie Kyon,Anene-Nzelu Chukwuemeka George,Ho Shamaine Wei Ting^ORCID,Ray Mohana,Ma Lijia,Fazzi Gregorio,Lim Kevin Junliang,Wijaya Giovani Claresta,Zhang Shenli,Nandi Tannistha^ORCID,Yan Tingdong,Chang Mei Mei,Das Kakoli^ORCID,Isa Zul Fazreen Adam,Wu Jeanie,Poon Polly Suk Yean,Lam Yue Ning,Lin Joyce Suling,Tay Su Ting^ORCID,Lee Ming Hui,Tan Angie Lay Keng,Ong Xuewen,White Kevin,Rozen Steven George,Beer Michael,Foo Roger Sik Yin,Grabsch Heike Irmgard,Skanderup Anders Jacobsen,Li Shang^ORCID,Teh Bin Tean^ORCID,Tan Patrick

Funder

National Medical Research Council

National University Cancer Institute, Singapore

Agency for Science, Technology and Research

Ministry of Education academic research, Singapore

Guangdong Innovative and Entrepreneurial Research Team Program, China

National Natural Science Foundation of China

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/126726/files/pdf

Reference65 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Benefit of adjuvant chemoradiotherapy for gastric adenocarcinoma: a SEER population analysis;Seyedin;Gastrointest Cancer Res,2014

3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

4. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

5. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities;PLOS Neglected Tropical Diseases;2024-09-05

2. Machine learning identifies activation of RUNX/AP-1 as drivers of mesenchymal and fibrotic regulatory programs in gastric cancer;Genome Research;2024-05

3. Super-enhancers: Implications in gastric cancer;Mutation Research - Reviews in Mutation Research;2024-01

4. CamoTSS: analysis of alternative transcription start sites for cellular phenotypes and regulatory patterns from 5' scRNA-seq data;Nature Communications;2023-11-09

5. EBF1 Promotes the Sensitivity of Cervical Cancer Cells to Cisplatin via Activating FBN1 Transcription;Molecular Biology;2023-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3